Thiamine Deficiency
A nutritional condition produced by a deficiency of THIAMINE in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, BERIBERI prevalence is very high. (From Cecil Textbook of Medicine, 19th ed, p1171)
Subtype terms (2)
More specific conditions that are subtypes of Thiamine Deficiency in the MeSH hierarchy.
- Beriberi
1 drug approved
- Wernicke Encephalopathy
7 drugs approved
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 1 trials (1)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (10)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Mahidol University
- Tufts University
- University of California, Davis
- University of California, San Francisco
- University of Vienna
- University of Indonesia
- Free University of Brussels
- Harapan Kita Hospital, Jakarta, Indonesia
- CHU Charleroi
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (8)